Patrick Stephen Gallagher

Chief Business Officer, Faeth Therapeutics, Inc.

Companies

Faeth Therapeutics, Inc.Chief Business Officer Jun 3, 2022 to Sep 11, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Faeth Therapeutics, Inc. FTH34,130 shares²$703.1K at $20.60Feb 15, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 15, 2023Granted 14,200 shares of Faeth Therapeutics, Inc.³
Feb 15, 2023Granted 14,200 shares of Faeth Therapeutics, Inc.⁴
Feb 15, 2023Granted 29,313 shares of Faeth Therapeutics, Inc.³
Feb 15, 2023Granted 29,313 shares of Faeth Therapeutics, Inc.⁴
Feb 15, 2023Shares withheld for tax 9,383 shares at $1.50 of Faeth Therapeutics, Inc.²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFaeth Therapeutics, Inc., Chief Business Officer
2
SEC EDGARFaeth Therapeutics, Inc. shares after the filing of Feb 15, 2023
3
SEC EDGARForm 4 filed Mar 29, 2023
4
SEC EDGARForm 4 filed Feb 17, 2023